Last viewed: SRNE


Prices are updated after-hours



nasdaq:SRNE Sorrento Therapeutics, Inc.

SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-26.6% 1m) (-57.2% 1y) (0.0% 2d) (-2.1% 3d) (0.2% 7d) (NaN% volume)
http://www.sorrentotherapeutics.com
Sec Filling | Patents | 310 employees

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

add to today's watch list email alert is off




cancer   covid   antibody   t-cell  

Press-releases


Sorrento Announces That Sorrento Mexico Has Sold Out of One Million COVISTIX Tests Last Week in Mexico
Published: 2022-01-19 (Crawled : 21:00) - globenewswire.com
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology

ces test
Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievement of Interim Analysis Threshold in the UK
Published: 2022-01-19 (Crawled : 17:00) - biospace.com/
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: -2.06% H: 0.0% C: 0.0%

phase 2 ces trial drop
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler)
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: 2.35% H: 0.0% C: 0.0%

covid-19 health phase 2 trial covid brazil
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | News | $90.49 | twitter stocktwits trandingview |
Health Technology
| | O: 1.26% H: 0.0% C: 0.0%
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: -5.96% H: 0.0% C: 0.0%
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 0.0% C: 0.0%
GILD | News | $70.28 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
BLUE | $7.55 | twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.0% C: 0.0%
JNJ | News | $167.165 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%

era cel therapy t-cell
Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government
Published: 2022-01-13 (Crawled : 15:30) - globenewswire.com
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.0% C: 0.0%

era therapeutics test
Dr. Henry Ji to Present at HC Wainwright BIOCONNECT Virtual Conference (January 10th – 13th)
Published: 2022-01-07 (Crawled : 17:00) - globenewswire.com
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: 0.66% H: 0.0% C: 0.0%

conference
Dr. Henry Ji to Participate in Longwood Healthcare Leaders Winter Webconference Panel on January 6th 2022
Published: 2022-01-04 (Crawled : 14:00) - globenewswire.com
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: 1.02% H: 0.81% C: -4.44%

health thc conference
WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody
Published: 2021-12-28 (Crawled : 01:00) - prnewswire.com
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: -1.26% H: 1.45% C: -10.73%

cd47 antibody
Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant
Published: 2021-12-27 (Crawled : 15:30) - globenewswire.com
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 0.52% C: -5.42%

covid-19 ces covid test
Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
Published: 2021-12-27 (Crawled : 20:00) - biospace.com/
SRNE | News | $4.27 | twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 0.52% C: -5.42%

contract era therapeutics test
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0001209191-21-055954 4 2021-09-14 Sell M 8000 0
0001209191-21-055954 4 2021-09-14 Sell S 8000 3000
0001209191-21-055954 4 2021-09-14 Buy M 8000 11000


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying